Reported Oct 22, 2025 · Ongoing
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca…
Astrazeneca Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: ASTRAZENECA PHARMACEUTICALS · 950 Wind River Ln · Gaithersburg, MD · 20878-1974
Is this the product you have?
- Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only
- Manufactured byAstraZeneca AB, Sweden
- Distributed byAstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
- Lot codes and dates
- Lot YJ0152
- Expiry01/31/2028
- Amount recalled
- 916 pre-filled syringes
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility:
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Astrazeneca Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.